New treatments for COPD: many miles still to go.
Clinical Science Centre, University Hospital Aintree, Longmoor Lane, Liverpool, L9 7AL, UK. Electronic address: pmacal@liverpool.ac.uk.
Peter M A
PM
Calverley
D003521:Cyclopropanes / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*
C543534:6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide; D003521:Cyclopropanes; D047428:Protein Kinase Inhibitors; D011725:Pyridines